Abstract
The present invention relates to novel glucofuranose esters
and glucopyranose esters of alkyl-fumarates. The esters are
suitable for use as active substances in the treatment of e.g.
psoriasis or other hyperproliferative, in?ammatory or
autoimmune disorders.
and glucopyranose esters of alkyl-fumarates. The esters are
suitable for use as active substances in the treatment of e.g.
psoriasis or other hyperproliferative, in?ammatory or
autoimmune disorders.
Original language | English |
---|---|
Patent number | US 2010/0144651 A1 |
Filing date | 7/7/06 |
Publication status | Published - Jun 10 2010 |